Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY: DHR )

236.75 USD +0.05 (+0.02%)
Official Closing Price Updated: 7:10 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Danaher CEO To Comment On Financial Performance
Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment today on the Company's fourth quarter 2020 performance in a... 
From PR Newswire
Danaher To Present At J.P. Morgan Healthcare Conference
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at... 
From PR Newswire
Danaher Schedules Fourth Quarter 2020 Earnings Conference Call
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2020 on Thursday, January 28, 2021 beginning at 8:00 a.m. ET and lasting... 
From PR Newswire
Danaher Announces Executive Appointment
Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos ("JC") Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Danaher. In this role, Dr. Gutierrez-Ramos... 
From PR Newswire
Beckman Coulter Launches the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S.
The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable 
From PR Newswire
Danaher announces leadership appointment
Danaher Corporation (NYSE: DHR) announced today that effective January 1, 2021, its Board of Directors has appointed Jennifer L. Honeycutt to the position of Executive Vice President of Danaher... 
From PR Newswire
Danaher Announces Quarterly Dividend
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on January 29, 2021 to holders... 
From PR Newswire
Companion Diagnostics Market Size, Share, Price, Trends, Growth, Analysis, Key Players, Outlook, Report, Forecast 2020-2025 | ExpertMarketResearch.com
Tags English Extended Distribution Reportedtimes
From iCrowdNewswire
Danaher To Present At Evercore ISI HealthCONx Conference
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conference on Tuesday, December 1, 2020 at 8:50... 
From PR Newswire
Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient's relative level of antibodies in response to a previous SARS-CoV-2 infection. The assay is an added tool to assess... 
From PR Newswire
Danaher To Present At Wolfe Research Healthcare Conference
Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Wolfe Research Healthcare Conference on Thursday, November... 
From PR Newswire
Danaher Releases 2020 Sustainability Report
Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") today published its 2020 Sustainability Report, highlighting key environmental, social and governance developments at the Company and... 
From PR Newswire
Beckman Coulter launches its SARS-CoV-2 IgM antibody test in countries accepting CE Mark and will begin shipping to diagnostics labs
Assay has 99.9% specificity and 98.3% sensitivity at 15-30 days post-symptom onset and confirmed 95.5% positive predictive value when disease incidence is as low as 3% 
From PR Newswire
Global Whole Health Partners Corp. (GWHP) Announces It now offers the new FDA cleared “Fingerstick” for rapid COVID-19 test results in minutes
Tags GWHP News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
UVC Radiation Devices & Disinfection Solutions Playing Major Role in Barrier Approach for Reducing Viruses
Financialnewsmedia.com News Commentary 
From PR Newswire
UVC Radiation Devices & Disinfection Solutions Playing Major Role in Barrier Approach for Reducing Viruses
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Cytiva strengthens support to diagnostics industry with new labs, services and supply chain enhancements
Cytiva launches new services for diagnostic developers and will establish new labs to meet the future needs of the industry. Cytiva Diagnostic Services will help developers bring point-of-care... 
From PR Newswire
Danaher Reports Third Quarter 2020 Results
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended October 2, 2020. All results in this release reflect only continuing operations unless otherwise noted. 
From PR Newswire
Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children
Large multi-center clinical trial is a collaborative effort between Beckman Coulter and academic partners at Massachusetts General Hospital, Johns Hopkins University School of Medicine and the... 
From PR Newswire
High Content Screening Market 2020: Analysis, Top Companies, Size, Share, Demand and Opportunity To 2025
Tags Technology
From AB Newswire
Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Use Authorization
Beckman Coulter, a clinical diagnostics leader, today announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug... 
From PR Newswire
Danaher Schedules Third Quarter 2020 Earnings Conference Call
Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2020 on Thursday, October 22, 2020 beginning at 8:00 a.m. ET and... 
From PR Newswire
Danaher Announces Redemption Of Senior Notes
Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it will redeem all of the €800,000,000 aggregate principal amount of 1.700% Senior Notes due 2022 (NYSE: DHR /22) issued by DH Europe... 
From PR Newswire
Beckman Coulter Completes First In A Series Of Antibody Neutralization Studies
Access SARS-CoV-2 IgG assay shows excellent agreement with surrogate virus neutralization test which identifies antibodies that block the interaction between virus and host cell receptor 
From PR Newswire
FDA Emergency Use Authorization awarded to the Beckman Coulter Access IL-6 test
The Access Interleukin-6 (IL-6) assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patients 
From PR Newswire
Danaher Announces Pricing Of Senior Notes Offering
Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of $1,000,000,000 principal amount of 2.600% senior notes due 2050 at an offering price of 98.970% of the... 
From PR Newswire
Cepheid Receives Emergency Use Authorization For SARS-CoV-2, Flu A, Flu B and RSV Combination Test
Challenged by Similar Clinical Presentations, Accurate Detection & Differentiation of all 4 Viruses is Critical for Clinicians This Flu Season 
From PR Newswire
Correction Notice To Press Release Regarding Dividend Amount
Danaher Corporation (NYSE: DHR) (the "Company") announced today a correction to the previously announced quarterly cash dividend payable on its 5.00% Series B Mandatory Convertible Preferred Stock. As... 
From PR Newswire
Danaher Announces Quarterly Dividend
Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on October 30, 2020 to holders... 
From PR Newswire
Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T
Based on its recent analysis of the global hematology testing market, Frost & Sullivan recognizes Beckman Coulter Diagnostics with the 2020 Global New Product Innovation Award for the DxH 690T. The... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.